Viridian Therapeutics Inc (VRDN)

11.63
-0.27(-2.27%)
  • Volume:
    59,208
  • Bid/Ask:
    11.41/11.69
  • Day's Range:
    11.63 - 12.12

VRDN Overview

Prev. Close
11.9
Day's Range
11.63-12.12
Revenue
2.59M
Open
11.94
52 wk Range
7.08-25.67
EPS
-29.66
Volume
59,208
Market Cap
110.97M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
58,437
P/E Ratio
-
Beta
1.58
1-Year Change
-8.49%
Shares Outstanding
9,542,087
Next Earnings Date
Nov 10, 2021
What is your sentiment on Viridian Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Viridian Therapeutics Inc News

Viridian Therapeutics Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellSell
Technical IndicatorsStrong SellSellStrong SellStrong SellSell
SummaryStrong SellSellStrong SellStrong SellSell

Viridian Therapeutics Inc Company Profile

Viridian Therapeutics Inc Company Profile

Employees
26

Viridian Therapeutics, Inc., formerly Miragen Therapeutics, Inc., is a biotechnology company. The Company is engaged in developing multiple product candidates to treat patients who suffer from thyroid eye disease (TED), a debilitating orphan disease, and has early-stage programs focused on other targets and indications. Its lead candidate, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody (mAb) that is under development for thyroid eye disease (TED). The Company's TED pipeline also includes VRDN-002 and VRDN-003. Its other programs include VRDN-004, which is under development for undisclosed rare orphan disease, and VRDN-005, which is under development for tick-borne disease (TBD). The Company also out licenses its programs.

Read More
  • Technical show this could see over $50 in the next 4-6 months. Buy the stock and not the option yet.
    0
    • This stock ***me
      0
      • Reverse stock split 15 for 1 from tomorrow session. Price will be adjusted
        0
        • if you have a position here, recommend to hold. Expected to boom sooon
          0
        • hi! Buy now at 15..? Or hold the old position which was at about 1. Its boomed suddenly!
          0
        • sell for the current price
          1
      • Look for $1.80 today!
        0
        • same number i put as my limit sell order lets go 🌊🏄🏻‍♂️
          0
        • alexander perezDid you guys sell?
          0
      • Can this hit 3$?
        0
        • WOW..
          1
          • Who is behind pumps like this? It’s just silly
            1
            • Don’t treat it as an investment, treat it as gambling
              0
              • Again I reiterate my advise never buy this stock, it's a trash, no one wants to put money on it even with its huge potential.
                0
                • oh, you were so wrong.
                  0
              • Never buy this stock guys after a great news it's a trap. Today it falls from 1.6 at opening to 1.21 at 1 pm.
                0
                • GREAT NEWS! Orphan Drug Designation!! https://stocktitan.net/news/MGEN/cobomarsen-receives-orphan-drug-designation-from-the-u-s-fda-for-the-lqk21onvtg8f.html Let's rocket!
                  0
                  • thanks
                    0
                • GREAT NEWS!! Orphan drug designation!! https://www.stocktitan.net/news/MGEN/cobomarsen-receives-orphan-drug-designation-from-the-u-s-fda-for-the-lqk21onvtg8f.html Let's rocket!
                  0
                  Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                  Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.